SlideShare a Scribd company logo
SITE MASTER FILE
Presented By:-
Sridhar s
1st M.Pharmacy
Pharmaceutical Regulatory Affairs
JSS College Of Pharmacy
Mysore
CONTENTS
• DEFINITION
• BENEFITS OF SMF
• CONTENTS
• REFERANCE
DEFINITION
• A site master file is a document prepared by the manufacturer
containing specific and factual GMP information about the
production and/or control of pharmaceutical manufacturing
operations carried out at the named site and any closely
integrated operations at adjacent and nearby buildings.
• A site master file or SMF is a document in the Pharmaceutical
Industry which provides information about the production and
control of manufacturing operations. The document is created
by a manufacturer e.g., analysis, packaging
BENEFITS OF SMF
• SITE MASTER FILE (SMF) provides a general overview of
the site and its operations.
• The Site Master File concept has been developed by PIC/S and
has become a standard expectation of inspectors.
• Pharmaceutical manufacturing activities at the site
• Type of product manufactured at the site
• Employees detailes
CONTENTS OF SMF
• It shall contains the following:-
• 1) General information:-
• (a) Brief information of the firm
• (b) Pharmaceutical manufacturing activities as permitted by
the licensing authority
• (c) Other manufacturing activities, if any, carried out on the
premises
• (d) Type of products licensed for manufacture with flowcharts
mentioning procedures and process flow
• (e) Number of employees engaged in the production, quality
control, storage and distribution
• (f) Use of outside scientific, analytical or other technical
assistance in relation to manufacture and analysis
• (g) Short description of the Quality Management system of the
firm
• (h) Products details registered with foreign countries.
• 2) PERSONNEL REQUIREMENT
• (a) Organizational chart showing the arrangement for quality
assurance including production and quality control
• (b) Qualification, experience and responsibilities of key
personnel
• (c) Outline for arrangements for basic and in-service training
and how the records are maintained
• (d) Health requirements for personal engaged in production
• (e) Personnel hygiene requirements, including clothing.
3. PREMISES
• (a) Simple plan or description of manufacturing areas drawn to
scale
• (b) Nature of construction and fixtures / fittings
• (c) Brief description of ventilation systems. More details
should be given for critical areas with potential risk of
airborne contamination (schematic drawing of systems)
• Classification of the rooms used for the manufacture of sterile
products should be mentioned
• (d) Special areas for the handling of the highly toxic,
hazardous and sensitizing materials
• (e) Brief description of water systems (schematic drawings of
systems), including sanitation
• (f) Description of planned preventive maintenance programs
for premises and of the recording system.
4.EQUIPMENT
• (a) Brief description of major equipment used in production
and quality control laboratories (a list of equipment required)
• (b) Description of planned preventive maintenance programs
for equipment and of the recording system
• (c) Qualification and calibration including the recording
systems and arrangements for computerized systems
validation.
5. SANITATION
• Availability of written specifications and procedures for
cleaning manufacturing areas and equipment.
6. DOCUMENTATION
• (a) Arrangements for the preparation, revision and distribution
of necessary documentation for the manufacture
• (b) Any other documentation related to product quality that is
not mentioned elsewhere (e.g. microbiological controls about
air and water)
7. PRODUCTION
• (a) Brief description of production operations using, wherever
possible, flow sheets and charts specifying important
parameters
• (b) Arrangements for the handling of starting materials,
packaging materials, bulk and finished products, including
sampling, quarantine, release and storage
PRODUCTION
• (c) Arrangements for the handling of rejected materials and
products
• (d) Brief description of general policy for process validation.
8. QUALITY CONTROL
• (a) Description of the Quality Control System and of the
activities of the Quality Control Department. Process for the
release of printed components and finished goods
• (b) Procedure for release of Finished Goods
• (c) Procedure for release of printed packaging material
9. Loan license manufacture and licensee
• (a) Description of the way in which compliance of Good
Manufacturing Practices by the loan licensee shall be
assessed.
10. DISTRIBUTION, COMPLAINTS AND
PRODUCT RECALL
• (a) Arrangements and recording system for
distribution
• (b) Arrangements for handling of complaints and
product recalls.
11. SELF INSPECTION
• (a) Short description of the Self Inspection System.
12. EXPORT OF DRUGS
• (a) Products exported to different countries
• (b) Complaints and product recall, if any.
REFERANCE
• http://www.cdsco.nic.in/html/gmp/scheduleM(
GMP).pdf
• https://en.wikipedia.org/wiki/Site_master_file
_(pharmaceuticals)
• http://www.grouppharma.in/GPL-SMF-
2010.pdf
Site master file

More Related Content

What's hot

CDER
CDERCDER
Cfr 21 part 11
 Cfr 21 part 11 Cfr 21 part 11
Cfr 21 part 11
Ashish Chaudhari
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
Current Good Manufacturing Practices
Current Good Manufacturing PracticesCurrent Good Manufacturing Practices
Current Good Manufacturing Practices
Swapnil Fernandes
 
Quality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaQuality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in India
S S N D Balakrishna Ch
 
Documentation In Pharmaceutical Industry.pptx
Documentation In Pharmaceutical Industry.pptxDocumentation In Pharmaceutical Industry.pptx
Documentation In Pharmaceutical Industry.pptx
saurabh11102000
 
CHANGE CONTROL
CHANGE CONTROLCHANGE CONTROL
CHANGE CONTROL
sonia nazir
 
Supplemental new drug application
Supplemental new drug applicationSupplemental new drug application
Supplemental new drug application
garimasaini33
 
BACPAC
BACPACBACPAC
BACPAC
Dhruvi50
 
ICH Q10 guideline.pptx
ICH Q10 guideline.pptxICH Q10 guideline.pptx
ICH Q10 guideline.pptx
02AishwaryaV
 
Pharmaceutical documentation
Pharmaceutical documentationPharmaceutical documentation
Pharmaceutical documentation
K V NANDA KUMAR
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
sandeep bansal
 
GMP compliances of Audit
GMP compliances of AuditGMP compliances of Audit
GMP compliances of Audit
Megha bhise
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
AMOGH DANDEKAR
 
ICH Guidelines Q1 - Q10
ICH Guidelines Q1 - Q10ICH Guidelines Q1 - Q10
ICH Guidelines Q1 - Q10
BHAGYASHRI BHANAGE
 
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
ICHAPPS
 
eCTD
eCTDeCTD

What's hot (20)

Change control
Change controlChange control
Change control
 
CDER
CDERCDER
CDER
 
Cfr 21 part 11
 Cfr 21 part 11 Cfr 21 part 11
Cfr 21 part 11
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
cGMP AS PER USFDA
 
Current Good Manufacturing Practices
Current Good Manufacturing PracticesCurrent Good Manufacturing Practices
Current Good Manufacturing Practices
 
Quality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaQuality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in India
 
Documentation In Pharmaceutical Industry.pptx
Documentation In Pharmaceutical Industry.pptxDocumentation In Pharmaceutical Industry.pptx
Documentation In Pharmaceutical Industry.pptx
 
Snda
SndaSnda
Snda
 
CHANGE CONTROL
CHANGE CONTROLCHANGE CONTROL
CHANGE CONTROL
 
Supplemental new drug application
Supplemental new drug applicationSupplemental new drug application
Supplemental new drug application
 
BACPAC
BACPACBACPAC
BACPAC
 
ICH Q10 guideline.pptx
ICH Q10 guideline.pptxICH Q10 guideline.pptx
ICH Q10 guideline.pptx
 
Pharmaceutical documentation
Pharmaceutical documentationPharmaceutical documentation
Pharmaceutical documentation
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
 
GMP compliances of Audit
GMP compliances of AuditGMP compliances of Audit
GMP compliances of Audit
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
 
ICH Guidelines Q1 - Q10
ICH Guidelines Q1 - Q10ICH Guidelines Q1 - Q10
ICH Guidelines Q1 - Q10
 
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
 
eCTD
eCTDeCTD
eCTD
 
BMR & MFR
BMR & MFRBMR & MFR
BMR & MFR
 

Similar to Site master file

GMP_Pharmaceutical_Facility_Design_Slide.pdf
GMP_Pharmaceutical_Facility_Design_Slide.pdfGMP_Pharmaceutical_Facility_Design_Slide.pdf
GMP_Pharmaceutical_Facility_Design_Slide.pdf
NinaDave2
 
ICH guidelines for validation Of Equipments by Nikita Sahu[1].pptx
ICH guidelines for validation Of Equipments by Nikita Sahu[1].pptxICH guidelines for validation Of Equipments by Nikita Sahu[1].pptx
ICH guidelines for validation Of Equipments by Nikita Sahu[1].pptx
NikitaSahu39
 
specific requirements of VMP.pdf
specific requirements of VMP.pdfspecific requirements of VMP.pdf
specific requirements of VMP.pdf
JikhilaMachado
 
Presentation1
Presentation1Presentation1
Presentation1
Arun Kumar
 
Drugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part VDrugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part V
Pranay Sethiya
 
Clean Room Pharmaceutical Good Manufacturing Process.pdf
Clean Room Pharmaceutical Good Manufacturing Process.pdfClean Room Pharmaceutical Good Manufacturing Process.pdf
Clean Room Pharmaceutical Good Manufacturing Process.pdf
HananZayed4
 
Clean Room Pharmaceutical_ GMP Procedures
Clean Room Pharmaceutical_ GMP ProceduresClean Room Pharmaceutical_ GMP Procedures
Clean Room Pharmaceutical_ GMP Procedures
HananZayed4
 
Design control FDA requirements
Design control FDA requirementsDesign control FDA requirements
Design control FDA requirements
Latvian University
 
Good manufacturing practices (schedule m)
Good manufacturing practices (schedule m)Good manufacturing practices (schedule m)
Good manufacturing practices (schedule m)
Bindu Kshtriya
 
Saiphali gmp-guidelines
Saiphali gmp-guidelinesSaiphali gmp-guidelines
Saiphali gmp-guidelines
kmsaiphali
 
Industrial pharmacy ii
Industrial pharmacy   iiIndustrial pharmacy   ii
Industrial pharmacy ii
WashifIslam
 
Manufacturing documents-GMP
Manufacturing documents-GMPManufacturing documents-GMP
Manufacturing documents-GMP
Swathi Nambiar
 
FMEA.pdf
FMEA.pdfFMEA.pdf
FMEA.pdf
infoqtc
 
Parag raj behura 190617006 designing effective urs and dq
Parag raj behura 190617006 designing effective urs and dqParag raj behura 190617006 designing effective urs and dq
Parag raj behura 190617006 designing effective urs and dq
Parag Behura
 
Facility & Equipment Quality System Outline
Facility & Equipment Quality System OutlineFacility & Equipment Quality System Outline
Facility & Equipment Quality System Outline
Joseph Busfield
 
pratik ghive cGMP According to schedule M
pratik ghive cGMP According to schedule Mpratik ghive cGMP According to schedule M
pratik ghive cGMP According to schedule M
pratikghive82
 
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptxUnit 4 Document maintenance in Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
AshwiniBhoir2
 

Similar to Site master file (20)

GMP_Pharmaceutical_Facility_Design_Slide.pdf
GMP_Pharmaceutical_Facility_Design_Slide.pdfGMP_Pharmaceutical_Facility_Design_Slide.pdf
GMP_Pharmaceutical_Facility_Design_Slide.pdf
 
ICH guidelines for validation Of Equipments by Nikita Sahu[1].pptx
ICH guidelines for validation Of Equipments by Nikita Sahu[1].pptxICH guidelines for validation Of Equipments by Nikita Sahu[1].pptx
ICH guidelines for validation Of Equipments by Nikita Sahu[1].pptx
 
specific requirements of VMP.pdf
specific requirements of VMP.pdfspecific requirements of VMP.pdf
specific requirements of VMP.pdf
 
Presentation1
Presentation1Presentation1
Presentation1
 
Drugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part VDrugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part V
 
Clean Room Pharmaceutical Good Manufacturing Process.pdf
Clean Room Pharmaceutical Good Manufacturing Process.pdfClean Room Pharmaceutical Good Manufacturing Process.pdf
Clean Room Pharmaceutical Good Manufacturing Process.pdf
 
Clean Room Pharmaceutical_ GMP Procedures
Clean Room Pharmaceutical_ GMP ProceduresClean Room Pharmaceutical_ GMP Procedures
Clean Room Pharmaceutical_ GMP Procedures
 
Design control FDA requirements
Design control FDA requirementsDesign control FDA requirements
Design control FDA requirements
 
Good manufacturing practices (schedule m)
Good manufacturing practices (schedule m)Good manufacturing practices (schedule m)
Good manufacturing practices (schedule m)
 
Saiphali gmp-guidelines
Saiphali gmp-guidelinesSaiphali gmp-guidelines
Saiphali gmp-guidelines
 
Industrial pharmacy ii
Industrial pharmacy   iiIndustrial pharmacy   ii
Industrial pharmacy ii
 
Manufacturing documents-GMP
Manufacturing documents-GMPManufacturing documents-GMP
Manufacturing documents-GMP
 
Presentation of industrial pharmacy 2 .r
Presentation of industrial pharmacy 2 .rPresentation of industrial pharmacy 2 .r
Presentation of industrial pharmacy 2 .r
 
Cleaning and analytical validation
Cleaning and analytical validationCleaning and analytical validation
Cleaning and analytical validation
 
FMEA.pdf
FMEA.pdfFMEA.pdf
FMEA.pdf
 
Parag raj behura 190617006 designing effective urs and dq
Parag raj behura 190617006 designing effective urs and dqParag raj behura 190617006 designing effective urs and dq
Parag raj behura 190617006 designing effective urs and dq
 
Facility & Equipment Quality System Outline
Facility & Equipment Quality System OutlineFacility & Equipment Quality System Outline
Facility & Equipment Quality System Outline
 
pratik ghive cGMP According to schedule M
pratik ghive cGMP According to schedule Mpratik ghive cGMP According to schedule M
pratik ghive cGMP According to schedule M
 
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptxUnit 4 Document maintenance in Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
 
DOCUMENTATION -- CoA & SPECIFICATIONS
DOCUMENTATION -- CoA & SPECIFICATIONSDOCUMENTATION -- CoA & SPECIFICATIONS
DOCUMENTATION -- CoA & SPECIFICATIONS
 

More from Sridhar S

TSE/BSE Evaluation
TSE/BSE EvaluationTSE/BSE Evaluation
TSE/BSE Evaluation
Sridhar S
 
Regulatory requirements for drug approval in Saudi Arabia
Regulatory requirements for drug approval in Saudi ArabiaRegulatory requirements for drug approval in Saudi Arabia
Regulatory requirements for drug approval in Saudi Arabia
Sridhar S
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
Sridhar S
 
Bis standards
Bis standardsBis standards
Bis standards
Sridhar S
 
FDA Warning letter
FDA Warning letterFDA Warning letter
FDA Warning letter
Sridhar S
 
Fda med watch
Fda med watchFda med watch
Fda med watch
Sridhar S
 

More from Sridhar S (6)

TSE/BSE Evaluation
TSE/BSE EvaluationTSE/BSE Evaluation
TSE/BSE Evaluation
 
Regulatory requirements for drug approval in Saudi Arabia
Regulatory requirements for drug approval in Saudi ArabiaRegulatory requirements for drug approval in Saudi Arabia
Regulatory requirements for drug approval in Saudi Arabia
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
 
Bis standards
Bis standardsBis standards
Bis standards
 
FDA Warning letter
FDA Warning letterFDA Warning letter
FDA Warning letter
 
Fda med watch
Fda med watchFda med watch
Fda med watch
 

Recently uploaded

Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 

Recently uploaded (20)

Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 

Site master file

  • 1. SITE MASTER FILE Presented By:- Sridhar s 1st M.Pharmacy Pharmaceutical Regulatory Affairs JSS College Of Pharmacy Mysore
  • 2. CONTENTS • DEFINITION • BENEFITS OF SMF • CONTENTS • REFERANCE
  • 3. DEFINITION • A site master file is a document prepared by the manufacturer containing specific and factual GMP information about the production and/or control of pharmaceutical manufacturing operations carried out at the named site and any closely integrated operations at adjacent and nearby buildings. • A site master file or SMF is a document in the Pharmaceutical Industry which provides information about the production and control of manufacturing operations. The document is created by a manufacturer e.g., analysis, packaging
  • 4. BENEFITS OF SMF • SITE MASTER FILE (SMF) provides a general overview of the site and its operations. • The Site Master File concept has been developed by PIC/S and has become a standard expectation of inspectors. • Pharmaceutical manufacturing activities at the site • Type of product manufactured at the site • Employees detailes
  • 5. CONTENTS OF SMF • It shall contains the following:- • 1) General information:- • (a) Brief information of the firm • (b) Pharmaceutical manufacturing activities as permitted by the licensing authority • (c) Other manufacturing activities, if any, carried out on the premises
  • 6. • (d) Type of products licensed for manufacture with flowcharts mentioning procedures and process flow • (e) Number of employees engaged in the production, quality control, storage and distribution • (f) Use of outside scientific, analytical or other technical assistance in relation to manufacture and analysis
  • 7. • (g) Short description of the Quality Management system of the firm • (h) Products details registered with foreign countries.
  • 8. • 2) PERSONNEL REQUIREMENT • (a) Organizational chart showing the arrangement for quality assurance including production and quality control
  • 9. • (b) Qualification, experience and responsibilities of key personnel • (c) Outline for arrangements for basic and in-service training and how the records are maintained • (d) Health requirements for personal engaged in production • (e) Personnel hygiene requirements, including clothing.
  • 10. 3. PREMISES • (a) Simple plan or description of manufacturing areas drawn to scale • (b) Nature of construction and fixtures / fittings • (c) Brief description of ventilation systems. More details should be given for critical areas with potential risk of airborne contamination (schematic drawing of systems) • Classification of the rooms used for the manufacture of sterile products should be mentioned
  • 11. • (d) Special areas for the handling of the highly toxic, hazardous and sensitizing materials • (e) Brief description of water systems (schematic drawings of systems), including sanitation • (f) Description of planned preventive maintenance programs for premises and of the recording system.
  • 12. 4.EQUIPMENT • (a) Brief description of major equipment used in production and quality control laboratories (a list of equipment required) • (b) Description of planned preventive maintenance programs for equipment and of the recording system • (c) Qualification and calibration including the recording systems and arrangements for computerized systems validation.
  • 13. 5. SANITATION • Availability of written specifications and procedures for cleaning manufacturing areas and equipment.
  • 14. 6. DOCUMENTATION • (a) Arrangements for the preparation, revision and distribution of necessary documentation for the manufacture • (b) Any other documentation related to product quality that is not mentioned elsewhere (e.g. microbiological controls about air and water)
  • 15. 7. PRODUCTION • (a) Brief description of production operations using, wherever possible, flow sheets and charts specifying important parameters • (b) Arrangements for the handling of starting materials, packaging materials, bulk and finished products, including sampling, quarantine, release and storage
  • 16. PRODUCTION • (c) Arrangements for the handling of rejected materials and products • (d) Brief description of general policy for process validation.
  • 17. 8. QUALITY CONTROL • (a) Description of the Quality Control System and of the activities of the Quality Control Department. Process for the release of printed components and finished goods • (b) Procedure for release of Finished Goods • (c) Procedure for release of printed packaging material
  • 18. 9. Loan license manufacture and licensee • (a) Description of the way in which compliance of Good Manufacturing Practices by the loan licensee shall be assessed.
  • 19. 10. DISTRIBUTION, COMPLAINTS AND PRODUCT RECALL • (a) Arrangements and recording system for distribution • (b) Arrangements for handling of complaints and product recalls.
  • 20. 11. SELF INSPECTION • (a) Short description of the Self Inspection System.
  • 21. 12. EXPORT OF DRUGS • (a) Products exported to different countries • (b) Complaints and product recall, if any.